Clover Health appoints Joseph Oldakowski as VP of Finance and Controller

WILMINGTON, Del. - Medicare-focused company Clover Health Investments, Corp. (NASDAQ:CLOV), which has seen its stock surge 75% over the past year and maintains a market capitalization of $1.54 billion, announced Thursday the appointment of Joseph Oldakowski as Vice President of Finance and Controller.

In his new role, Oldakowski will report to Chief Financial Officer Peter Kuipers and lead the company’s corporate accounting, financial reporting, and tax functions. He joined the company in June after nearly two decades in finance and accounting leadership positions.

Oldakowski previously served as Vice President and Corporate Controller at Point32Health, where he managed the financial integration following the merger of Harvard Pilgrim Health Care and Tufts Health Plan. His prior experience includes roles as Corporate Controller at EmblemHealth and leadership positions at The Hartford and MassMutual.

"Joe’s deep technical expertise, track record of leading complex finance transformations, and commitment to integrity make him a strong addition to the Clover leadership team," said Kuipers in the press release.

Oldakowski holds a Master’s Degree in Accounting and Taxation from the University of Hartford and a Bachelor’s Degree in Accountancy from Bentley University. He began his career in public accounting with Melanson Heath, now part of Marcum LLP, specializing in healthcare and nonprofit organization audits.

Clover Health describes itself as a physician enablement technology company focused on providing Medicare Advantage plans and developing its Clover Assistant software platform designed to support clinical decision-making and improve health outcomes. The company has demonstrated strong revenue growth of 15.62% in the last twelve months, generating $1.49 billion in revenue. According to InvestingPro analysis, Clover Health maintains a "GREAT" financial health score, with analysts expecting profitability this year. Investors can access detailed financial analysis and 8 additional exclusive ProTips through InvestingPro’s comprehensive research report.

In other recent news, Clover Health Investments Corp reported impressive financial results for the first quarter of 2025, with a 33% increase in revenue, reaching $457 million. The company also saw a 30% growth in its Medicare Advantage membership, contributing to a significant 279% rise in adjusted EBITDA year-over-year. Clover Health ended the quarter with $391 million in cash and investments, demonstrating strong liquidity. The company has raised its full-year 2025 guidance, expecting insurance revenue between $1.8 billion and $1.875 billion and adjusted EBITDA projections of $50-$70 million.

Additionally, Clover Health engaged with its shareholders by responding to selected questions in an effort to maintain transparency and open communication. These responses were published on the company’s website and included in a filing with the Securities and Exchange Commission. The company continues to operate without a traditional headquarters, maintaining a remote-first business model. Clover Health’s strategic initiatives and focus on innovation have positioned it well for continued growth in a competitive Medicare Advantage market. The company’s recent developments reflect its ongoing commitment to fostering a well-informed investor community.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.